Excellence across the board at the 2024 Euretina Congress
This year’s Barcelona meeting brought together award-winning research findings and leaders in the retina field.
A-memia? Anecdotal evidence in the era of memes
Ian C. Han, MD, shares his thoughts on the value of anecdotal evidence in our winter 2024 editorial.
New treatment options provide effective management of geographic atrophy
In a recent Modern Retina case-based discussion, Ferhina S. Ali, MD, MPH, discussed how to effectively manage geographic atrophy (GA).
Ocular nerve regrowth following use of diabetes drug
A case report demonstrates independent effect of GLP-1 receptor agonist.
The deep dish on all things ophthalmology at AAO 2024
The annual meeting, held in Chicago, Illinois, featured new data and best practices for patient-centered care.
Identifying and monitoring GA: Technologic improvements over time
Srinivas R. Sadda, MD, described the advantages and disadvantages of the various imaging technologies used to evaluate GA at the AAO 2024 conference.
Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomes
Neovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Advancements in ocular drug delivery
Options empower patients and providers to decrease treatment burden
A field guide to optic disc drusen
Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilledema.
